chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Chills, Cough, Diarrhoea
Clinical narrative: Extremely ill for 2 days, sores in my mouth and nostrils, hallucination. BP was high, diarrhea, chills, no fever weak and fatigue and couldn't get out of bed, 11 and 12 Sep2021. I thought I was going to feel better but I didn't saw my doctor 28 Sep2021. Gave prednisone and changed BP medicine. BP gone down but heart rate 107 this am, yesterday was 119 and 113- shortness of breath. Dry cough heart high, bp not perfect, I cant do much without having shortness of breath. Prednisone is finished and going back to the doctor soon.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Fatigue, Full blood count normal, Hallucination
Clinical narrative: Extremely ill for 2 days, sores in my mouth and nostrils, hallucination. BP was high, diarrhea, chills, no fever weak and fatigue and couldn't get out of bed, 11 and 12 Sep2021. I thought I was going to feel better but I didn't saw my doctor 28 Sep2021. Gave prednisone and changed BP medicine. BP gone down but heart rate 107 this am, yesterday was 119 and 113- shortness of breath. Dry cough heart high, bp not perfect, I cant do much without having shortness of breath. Prednisone is finished and going back to the doctor soon.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hypertension, Malaise, Mobility decreased, Stomatitis
Clinical narrative: Extremely ill for 2 days, sores in my mouth and nostrils, hallucination. BP was high, diarrhea, chills, no fever weak and fatigue and couldn't get out of bed, 11 and 12 Sep2021. I thought I was going to feel better but I didn't saw my doctor 28 Sep2021. Gave prednisone and changed BP medicine. BP gone down but heart rate 107 this am, yesterday was 119 and 113- shortness of breath. Dry cough heart high, bp not perfect, I cant do much without having shortness of breath. Prednisone is finished and going back to the doctor soon.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Angiogram cerebral abnormal, Anosmia, Anticoagulant therapy, Blood culture
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure decreased, COVID-19, Cardio-respiratory arrest, Cerebral endovascular aneurysm repair, Cerebral vasoconstriction
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Cough, Death, Deep vein thrombosis
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, General physical health deterioration, Hypophagia, Inappropriate schedule of product administration, Intracranial aneurysm
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intraventricular haemorrhage, Laboratory test, Lethargy, Mechanical ventilation, Mental status changes
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pneumonia, Positive airway pressure therapy, Pulse absent, Respiratory tract congestion
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Resuscitation, SARS-CoV-2 test positive, Sputum culture, Subarachnoid haemorrhage, Tachycardia
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/23/2021. Patient presented to physician office on 9/3/2021 after developing COVID symptoms of cough, sore throat, congestion, loss of taste and smell 4-5 days prior, as well as reports that daughter had recently tested COVID positive. Patient received Casirivimab and Imdevimab on 9/6/2021.  On 9/28/2021 patient presented to the ED for altered mental status.  She was found to have a subarachnoid hemorrhage and was admitted with consultation to the Stroke team.  She was intubated on 9/30/2021. BCx2, Pneumonia Panel, Sputum culture without any organism found. She underwent diagnostic cerebral angiogram and subsequent coiling of the anterior communicating artery aneurysm on 9/30/20201.  On 10/01/2021 she was awake and following commands.  After completing a spontaneous breathing trial she was successfully extubated.  She was initially communicating, following commands, and A&O x 3.   Over the night of 10/02/2021 she had increasing O2 demands and was placed on HFNC.  She was tachycardic on 10/03/2021, she was more lethargic and would not swallow sips of water.   A sepsis work up was initiated along with DVT studies do to history of Essential Thrombocytosis.  She was found to have DVTs in BL upper extremities and R lower extremity. She required BIPAP to maintain ventilation. She was sent for CT/CTA of head which noted slightly increased intravenricular hemorrhage and vasospasm of the right ACA, left ACA, and left MCA.  CT Chest was consistent with multifocal pneumonia.  She was increased to subcutaneous heparin TID with ASA 81 mg.  On 10/4/2021 she continued to regress.  The morning of 10/05/2021 she would respond only to pain stimulus.  She was evaluated again with CT with worsening vasospasm.  Patient was intubated, after which her BP dropped  Two attempts were made with push dose Phenylephrine to increase BP with out success.  Her pulse was lost and compressions were started.  Code Blue was called.  Family was informed of the changes to her status and  they decided to stop chest compressions and let her pass peacefully.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Alopecia, Amenorrhoea, Pregnancy
Clinical narrative: After I received my first vaccine I stopped having periods completely. I didn?t not have a period at all until may when I found out I was 7 weeks pregnant. But before becoming pregnant, December 2020-April 2021, I never had a period. I had very regularly periods before the vaccine. I also developed acne and hair loss, that still has not resolved.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Herpes zoster, Neck pain, Neuritis
Clinical narrative: I have symptoms of shingles the inflammation of the nerves excessive pain in the lower back and hip left side and back of the neck.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: PATIENT HAD PFIZER VACCINE ON 01/21/2021 and 02/11/2021, AND TESTED POSITIVE TO COVID.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse reaction occurred. Patient presented with consent form listing date of birth signed by legal guardian requesting to receive first dose of Pfizer COVID-19 vaccine . Per policy, the legal guardian who signed the consent form was contacted prior to administration to confirm consent and consent was documented on 8/31/21. Patient received vaccine.  As there was no profile in the database for patient with name and DOB combination, a new profile was entered. Prior to appointment for the second dose scheduled for 9/21/21, a staff pharmacist determined that a database profile existed for a patient with the same name and a different date of birth. As the Pharmacy Manager, I contacted the patient's legal guardian and received a return call from the patient's grandfather. When asked to confirm the patients date of birth , he stated false birthdate. Because two entries existed in the database, I asked that he bring proof of the patient's date of birth to the appointment for validation. He stated he would not be able to do so in time for the appointment and I asked him to reschedule and provide proof prior to administration. The pharmacy was not contacted again and no appointment was rescheduled. Suspect that date of birth might have been falsified on consent form and that Pfizer COVID vaccine was administered to a 9 year old.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Impaired work ability, Muscle rigidity, Parkinson's disease
Clinical narrative: His Parkinson's rigidity increased within a day or two, causing inability to work effectively, cannot type, had to increase routine medications.  He is now six months later with no resolution
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Death
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/13/2021. Patient presented to the emergency department with complaints of shortness of breath and admitted for COVID pneumonia. Patient progressed to respiratory failure requiring intubation on 9/16/2021. Despite lung protective mechanical ventilation, paralysis, proning, inhaled pulmonary vasodilators, steroids, broad spectrum antibiotics, and remdesivir, her respiratory failure progressively worsened. On 9/25/2021 patient developed acute renal failure with worsening shock.  Family elected to pursue comfort care at that time. Patient was extubated on 9/25/2021, and expired at 2107 on 9/25/2021.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Lung opacity, Mechanical ventilation, Paralysis
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/13/2021. Patient presented to the emergency department with complaints of shortness of breath and admitted for COVID pneumonia. Patient progressed to respiratory failure requiring intubation on 9/16/2021. Despite lung protective mechanical ventilation, paralysis, proning, inhaled pulmonary vasodilators, steroids, broad spectrum antibiotics, and remdesivir, her respiratory failure progressively worsened. On 9/25/2021 patient developed acute renal failure with worsening shock.  Family elected to pursue comfort care at that time. Patient was extubated on 9/25/2021, and expired at 2107 on 9/25/2021.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Prone position, Respiratory failure, SARS-CoV-2 test positive, Shock
Clinical narrative: Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 2/13/2021. Patient presented to the emergency department with complaints of shortness of breath and admitted for COVID pneumonia. Patient progressed to respiratory failure requiring intubation on 9/16/2021. Despite lung protective mechanical ventilation, paralysis, proning, inhaled pulmonary vasodilators, steroids, broad spectrum antibiotics, and remdesivir, her respiratory failure progressively worsened. On 9/25/2021 patient developed acute renal failure with worsening shock.  Family elected to pursue comfort care at that time. Patient was extubated on 9/25/2021, and expired at 2107 on 9/25/2021.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Chest discomfort, Insomnia, Malaise, Palpitations
Clinical narrative: Rescue Ambulance Report: ON SCENE TO  FACILITY FOR A 35 YEAR OLD M IN MILD DISTRESS, AOX3 GCS 15 W CC CHEST PRESSURE THAT BEGAN AT 4AM. PROVIDER IMPRESSION CHEST PAIN CARDIAC. PT STATES HE TOOK HIS FIRST DOSE OF JNJ VACCINATION YESTERDAY NOON. TODAY IN THE AM PT HAD DIFFICULTY SLEEPING AND WAS RESTLESS THROUGH THE NIGHT. PT WAS ABLE TO FALL ASLEEP AT 2AM AND AWOKE AT 4AM WITH CHEST PRESSURE, PALPITATIONS, AND FELT UNWELL. ON ARRIVAL OF RA PT HAS 5/10 CHEST PRESSURE WITH NO LASTING RELIEF FROM 3 SPRAYS OF NITRO. 162MG ASPIRIN ADMINISTERED, SINUS TACH ON 12 LEAD. NO LOC, NO SOB, NO NAUSEA OR VOMITING, NO NEURO DEFICITS, NO ABDOMINAL PAIN, NO OBVIOUS TRAUMA, NO OTHER COMPLAINTS. ALL MEDS AND TREATMENTS DONE BY ON SCENE PARAMEDIC . NO ADDITIONAL TREATMENTS WHILE ENROUTE TO HOSPITAL IN RA3. PT STATES THESE SYMPTOMS ARE IDENTICAL TO HOW HE FELT 6 YEARS AGO WHEN HE WAS DIAGNOSED AND TREATED FOR MYO PERICARDITIS. PT WAS ASSISTED ON TO GURNEY, SECURED IN AMBULANCE, TRANSPORTED TO HOSPITAL 139 PER PT REQUEST. IN STABLE CONDITION, MOVED TO HOSPITAL BED WITHOUT INCIDENT, TRANSFERRED CARE TO RN.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: Rescue Ambulance Report: ON SCENE TO  FACILITY FOR A 35 YEAR OLD M IN MILD DISTRESS, AOX3 GCS 15 W CC CHEST PRESSURE THAT BEGAN AT 4AM. PROVIDER IMPRESSION CHEST PAIN CARDIAC. PT STATES HE TOOK HIS FIRST DOSE OF JNJ VACCINATION YESTERDAY NOON. TODAY IN THE AM PT HAD DIFFICULTY SLEEPING AND WAS RESTLESS THROUGH THE NIGHT. PT WAS ABLE TO FALL ASLEEP AT 2AM AND AWOKE AT 4AM WITH CHEST PRESSURE, PALPITATIONS, AND FELT UNWELL. ON ARRIVAL OF RA PT HAS 5/10 CHEST PRESSURE WITH NO LASTING RELIEF FROM 3 SPRAYS OF NITRO. 162MG ASPIRIN ADMINISTERED, SINUS TACH ON 12 LEAD. NO LOC, NO SOB, NO NAUSEA OR VOMITING, NO NEURO DEFICITS, NO ABDOMINAL PAIN, NO OBVIOUS TRAUMA, NO OTHER COMPLAINTS. ALL MEDS AND TREATMENTS DONE BY ON SCENE PARAMEDIC . NO ADDITIONAL TREATMENTS WHILE ENROUTE TO HOSPITAL IN RA3. PT STATES THESE SYMPTOMS ARE IDENTICAL TO HOW HE FELT 6 YEARS AGO WHEN HE WAS DIAGNOSED AND TREATED FOR MYO PERICARDITIS. PT WAS ASSISTED ON TO GURNEY, SECURED IN AMBULANCE, TRANSPORTED TO HOSPITAL 139 PER PT REQUEST. IN STABLE CONDITION, MOVED TO HOSPITAL BED WITHOUT INCIDENT, TRANSFERRED CARE TO RN.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Insomnia, Lymphadenopathy, Pain in extremity
Clinical narrative: have this weird symptom that started 10/6. my left arm pit stared to get sore, then swollen, and is now so tender i couldnt sleep and can barely let my arm rest at my side. it is the arm that got the injection. maybe lymph nodes? the outside of my arm is tender as expected but the arm pit and my left breast is where it has settled
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: have this weird symptom that started 10/6. my left arm pit stared to get sore, then swollen, and is now so tender i couldnt sleep and can barely let my arm rest at my side. it is the arm that got the injection. maybe lymph nodes? the outside of my arm is tender as expected but the arm pit and my left breast is where it has settled
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine
Clinical narrative: migraines have increased by at least 50% where I was having them 1 to 2 a week before vaccine I now have them 5 days a week.  Doctor pu me on medication that we had to change as of 10/7/2021 due to messing with heaviness of chest and shortness of breath.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Throat tightness
Clinical narrative: Patient complaint of tightness in throat and upper chest lasted 3-4 minutes. No SOB, no rash, skin warm and dry, color good, no pain. vitals 167-98, pulse 78. Complaint resolved 2:30
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Diarrhoea, Eye pain, Headache, Pain in extremity
Clinical narrative: I had severe pain after the shot around my left eye and temple area and diarrhea, more recently I have a pain around the back of my left leg, right above the knee area. And the front of my left leg looks and feels bruised as it I was struck by something
Age: 29.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain, X-ray
Clinical narrative: 29-year-old female received a flu shot on 09/15/2021 at the mass vaccination clinic.  She reports that the shot may have been administered higher than usual and felt the injection in her upper arm. She had pain after the injection which has worsened since. She tells me that she had not any previous reactions or difficulties previously. She tells me that she has been using Advil which helps a little.  She denies any fevers, numbness or tingling. On presentation she reports that she had constant pain rated 1-2/10 while sitting the waxes and wanes, is throbbing and made worse with increased activity of the RUE.  She denies PMH, allergic to medications.  She uses Ocella, Spironolactone for acne and Zyrtec for seasonal allergies. She denies any recent illnesses. She denies possibility of pregnancy.
Age: 43.0
Sex: F
Vaccine: FLUA4
Symptoms: Headache, Nausea, Throat tightness, Vision blurred
Clinical narrative: headache, nausea, throat tightening sensation, blurry vision
Age: 6.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Extra dose administered
Clinical narrative: When identifying the patient, the mother was unclear which child was which despite the identification process and placed the wrong child in the chair for her shots, despite a second check in indicating the type of shots she was getting that day.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient used fake names and received full series of all approved vaccines. It was not caught until he received his final dose of Moderna
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia oral, Lip oedema, Paraesthesia oral
Clinical narrative: Patient received vaccine at 1:45pm, at 2:15pm complained of numbness and tingling of lips, edema of lips noted. No complaints of shortness of breath, chest pain, no pruritus or hives noted. Benadryl 50 mg elixir given. To ER via 911. Per Patient, treated in ER with steroids. Sent home with steroids, Benadryl and Epi pen.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: PATIENT HAD MODERNA VACCINE ON 04/23/2021 and 05/21/2021, AND TESTED POSITIVE TO COVID.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Peripheral swelling, Swelling face
Clinical narrative: Swelling of hands and face. Cold feet
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Musculoskeletal stiffness, Pain in extremity, Periarthritis, Sleep disorder
Clinical narrative: I was fine for a couple of days and as my husband was healing I was asking if his arm hurt and his was fine and mine just hurt. I went to the Doctor because I'm anemic and I couldn't get up that night off of the couch and I had to get a b12 shot and my arm locked. They said they couldn't give me shot because of my arm and they had to send me to ER and they determined it was due to vaccine and they injected it into the wrong area of arm that caused frozen shoulder and my shoulder locked and I'm in constant pain. I went to physical therapy and Dr. told me they think it's due to shot and they injected the vaccine into a calcium deposit in arm. Now my arm is sore with frozen shoulder and I've had two cortisone shots and it doesn't seem to be helping. After a year I might have to have surgery. I can't even sleep on that arm anymore. Now I can't use my arm. I don't think I had reaction from actual vaccine but the way it was administered.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Ear pain, External ear inflammation, Hypoacusis, Lymphadenopathy
Clinical narrative: Face swelling/congestion,  lymphnodes under my under arm breast left side, right arm nodes at elbow, left neck and sores in mouth. Earpain, inflamation, hard to hear on right ear and vertigo in both ears. vomiting, Visited urgent care on 9/28/2021 prescribed antibiotic, prednisone and meclazine for dizzy/motion sickness. I still have symptoms and follow up visit is on October 15, 2021.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Motion sickness, Respiratory tract congestion, Stomatitis, Swelling face, Vertigo
Clinical narrative: Face swelling/congestion,  lymphnodes under my under arm breast left side, right arm nodes at elbow, left neck and sores in mouth. Earpain, inflamation, hard to hear on right ear and vertigo in both ears. vomiting, Visited urgent care on 9/28/2021 prescribed antibiotic, prednisone and meclazine for dizzy/motion sickness. I still have symptoms and follow up visit is on October 15, 2021.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Face swelling/congestion,  lymphnodes under my under arm breast left side, right arm nodes at elbow, left neck and sores in mouth. Earpain, inflamation, hard to hear on right ear and vertigo in both ears. vomiting, Visited urgent care on 9/28/2021 prescribed antibiotic, prednisone and meclazine for dizzy/motion sickness. I still have symptoms and follow up visit is on October 15, 2021.
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Adverse event, Back pain, Chills, Cough, Headache
Clinical narrative: Patient began experiencing adverse effects October 2 (8 days after the immunization). He reported uncontrollable trembling, chills, cough, nausea, back pain, headaches.  On October 7th he came to the pharmacy with a raised circular rash solely at the injection site. His other symptoms have become less prevalent. He is still coughing and still has body aches in addition to the rash. Patient was referred to the local urgent care to undergo evaluation for his symptoms and rash.
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site rash, Nausea, Pain, Tremor
Clinical narrative: Patient began experiencing adverse effects October 2 (8 days after the immunization). He reported uncontrollable trembling, chills, cough, nausea, back pain, headaches.  On October 7th he came to the pharmacy with a raised circular rash solely at the injection site. His other symptoms have become less prevalent. He is still coughing and still has body aches in addition to the rash. Patient was referred to the local urgent care to undergo evaluation for his symptoms and rash.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site pruritus, Injection site urticaria, Injection site warmth, Pain in extremity
Clinical narrative: Initially/same day patient had no adversities. The next day arm was extremely sore and had a small wheal in the area that she had been vaccinated in. According to the patient 9/29 It was about the size of a quarter. The following day it had increased to size 8cmx5cm the 30th. Patient complained it was inflamed and itchy and  hot to the touch. The patient took ibuprofen and iced the area. Per the patient it eventually resolved and was much less visible by the 10/5. Patient had no other side effects.
Age: 61.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Lymph node pain, Lymphadenopathy
Clinical narrative: Large red lump in axilla, appears to be swollen lymph node, painful to touch
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure, Syncope
Clinical narrative: Patient received vaccine, and during 15 minute post-vaccine waiting period, collapsed and experienced what appeared to be a seizure. Patient quickly regained consciousness and was provided supportive care according to company policy and procedures. Patient declined emergency services when asked. Patient was given Benadryl 25 mg PO x1 dose and observed for >1 hour prior to discharge from pharmacy waiting area.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Fatigue, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: sore throat, cough, runny nose, headache, sinus congestion, nasal congestion, wheezing, post nasal drainage, fatigue, nonproductive cough, body aches. starting on 10/3/21.  First vaccine given through employer, unable to access LOT #
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Rhinorrhoea, Sinus congestion, Upper-airway cough syndrome, Wheezing
Clinical narrative: sore throat, cough, runny nose, headache, sinus congestion, nasal congestion, wheezing, post nasal drainage, fatigue, nonproductive cough, body aches. starting on 10/3/21.  First vaccine given through employer, unable to access LOT #
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity, Peripheral swelling
Clinical narrative: lt leg swollen and hurts, bruises on rt arm
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: 12 year old male light headed and feel like he was going to pass out. Patient taken to EMS room to lay down. Patient felt better after 5 minutes of rest on cot. @1415, Patient sat on edge of bed and tolerated without any problem. @1425, patient walked out without any trouble.  P: 64, BP: 128/80,  SAT 98%.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache multiple times per day every day
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Chills, Decreased appetite
Clinical narrative: Muscle spasms in lower & mid back, lower back pain, pain front of hips, quads painful & weak, extremely painful headache, stiff neck, fever of 101.2, chills, night sweats, kept waking up throughout night, elevated heart rate (more than 10 bpm above normal), sinus pressure, no appetite, nausea, decreased heart rate variability
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Heart rate variability decreased, Muscle spasms, Musculoskeletal stiffness
Clinical narrative: Muscle spasms in lower & mid back, lower back pain, pain front of hips, quads painful & weak, extremely painful headache, stiff neck, fever of 101.2, chills, night sweats, kept waking up throughout night, elevated heart rate (more than 10 bpm above normal), sinus pressure, no appetite, nausea, decreased heart rate variability
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Pain in extremity, Paranasal sinus discomfort, Pyrexia
Clinical narrative: Muscle spasms in lower & mid back, lower back pain, pain front of hips, quads painful & weak, extremely painful headache, stiff neck, fever of 101.2, chills, night sweats, kept waking up throughout night, elevated heart rate (more than 10 bpm above normal), sinus pressure, no appetite, nausea, decreased heart rate variability
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Muscle spasms in lower & mid back, lower back pain, pain front of hips, quads painful & weak, extremely painful headache, stiff neck, fever of 101.2, chills, night sweats, kept waking up throughout night, elevated heart rate (more than 10 bpm above normal), sinus pressure, no appetite, nausea, decreased heart rate variability
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was only 16 years old when she received Moderna vaccine
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: complained of left arm numbness that occurred the day after vaccination that has spread to the fingers, which has continued to this date.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: None.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase, C-reactive protein normal, Dysgeusia, Electrophoresis abnormal, Nerve stimulation test abnormal
Clinical narrative: I have had a metallic taste in my mouth since mid to late March and I began developing neuropathies in my hands and feet at the same time. They would come and go, but now do not go. I lost weight without trying but because nothing tastes good.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Scleroderma-like reaction, Vitamin B12 normal, Weight decreased
Clinical narrative: I have had a metallic taste in my mouth since mid to late March and I began developing neuropathies in my hands and feet at the same time. They would come and go, but now do not go. I lost weight without trying but because nothing tastes good.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Chronic inflammatory demyelinating polyradiculoneuropathy, Gait disturbance, Hypoaesthesia
Clinical narrative: Adverse event(s)-enjoyed normal activities including golfing, bowling, mowing, household repairs including climbing and lifting.  Over night became unable to do any of these things due to pain, numbness, and tingling affecting back, spine, and legs.  Walking gait became severely distorted.  Started using cane, gait still distorted.  Started using walker which helped mobility.  Still distorted walking gait if walker not used.  These abnormalities began within two weeks of second Covid-19 shot which was administered March 2, 2021.  Medical expertise commenced March 29, 2021 which has continued as of this report dated October 7, 2021.  This has included trips to primary care physician, physical therapists, neurosurge
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Loss of personal independence in daily activities, Lumbar puncture, Magnetic resonance imaging spinal, Nerve conduction studies
Clinical narrative: Adverse event(s)-enjoyed normal activities including golfing, bowling, mowing, household repairs including climbing and lifting.  Over night became unable to do any of these things due to pain, numbness, and tingling affecting back, spine, and legs.  Walking gait became severely distorted.  Started using cane, gait still distorted.  Started using walker which helped mobility.  Still distorted walking gait if walker not used.  These abnormalities began within two weeks of second Covid-19 shot which was administered March 2, 2021.  Medical expertise commenced March 29, 2021 which has continued as of this report dated October 7, 2021.  This has included trips to primary care physician, physical therapists, neurosurge
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, Spinal X-ray, Spinal pain, Vitamin B12 decreased
Clinical narrative: Adverse event(s)-enjoyed normal activities including golfing, bowling, mowing, household repairs including climbing and lifting.  Over night became unable to do any of these things due to pain, numbness, and tingling affecting back, spine, and legs.  Walking gait became severely distorted.  Started using cane, gait still distorted.  Started using walker which helped mobility.  Still distorted walking gait if walker not used.  These abnormalities began within two weeks of second Covid-19 shot which was administered March 2, 2021.  Medical expertise commenced March 29, 2021 which has continued as of this report dated October 7, 2021.  This has included trips to primary care physician, physical therapists, neurosurge
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Walking aid user
Clinical narrative: Adverse event(s)-enjoyed normal activities including golfing, bowling, mowing, household repairs including climbing and lifting.  Over night became unable to do any of these things due to pain, numbness, and tingling affecting back, spine, and legs.  Walking gait became severely distorted.  Started using cane, gait still distorted.  Started using walker which helped mobility.  Still distorted walking gait if walker not used.  These abnormalities began within two weeks of second Covid-19 shot which was administered March 2, 2021.  Medical expertise commenced March 29, 2021 which has continued as of this report dated October 7, 2021.  This has included trips to primary care physician, physical therapists, neurosurge
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Pain, Pain in jaw
Clinical narrative: patient complained of sharp pain from left inner ear radiating to upper left jaw, pain scaled 6/10 intermittent pain noted. Vital signs 100/60, P-69, O2 - 99%, RR-17. Patient given an ice pack to apply over the painful area. Pt verbalizes relief of pain. 20 mins after ice application > relief of pain noted and with reported pain scale of 3/10. Patient went home with relief of pain, reported pain scale 0/10 and stable vital signs, no dizziness, or headache noted. Vital signs BP 112/66, P-62, RR-18, 02 sat 99%
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Chest discomfort, Dyspnoea, Electrocardiogram normal, Laboratory test normal
Clinical narrative: The day after the vaccine she started having chest discomfort, feels like a pressure that will not go away. She also noticed that her blood pressure has been elevated.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: The day after the vaccine she started having chest discomfort, feels like a pressure that will not go away. She also noticed that her blood pressure has been elevated.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Oedema peripheral
Clinical narrative: Lump and soreness in the armpit of the injected arm.